Medtronic (MDT) –
-
Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity
-
Americans favor quality over quantity in pursuit of longevity
-
Medtronic, Inc. (MDT) PT Lowered to $88 at Baird
-
Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care
-
Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care
-
Medtronic (MDT) unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
-
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
-
Form 4 Medtronic plc For: Apr 08 Filed by: Marinaro Michael
-
Medtronic (MDT) Sphere-360 PFA catheter demonstrates impressive results in treating paroxysmal atrial fibrillation
-
The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation
-
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
-
New survey uncovers lack of awareness around heart valve disease and risk factors among women
-
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
-
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market Growth
-
Medtronic (MDT) Receives FDA Approval of Next-gen Evolut TAVR System
-
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
-
Axonics (AXNX) Provides Update on Inter Partes Review Proceedings
-
Medtronic (MDT) Announces US Patent Office Rejected Axonics' Latest Challenge to its patents
-
U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents
-
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
-
New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management
-
Medtronic announces cash dividend for fourth quarter of fiscal year 2024
-
Form 4 Medtronic plc For: Mar 05 Filed by: Marinaro Michael
-
Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference
-
Medtronic Once Again Named One of the World's Most Ethical Companies
-
Axonics, Inc. (AXNX) Responds to ITC Action by Medtronic (MDT)
-
Medtronic (MDT) Files ITC Action Against Axonics to Stop Use of Medtronic Innovations
-
Medtronic files ITC action against Axonics to stop unauthorized use of Medtronic innovations
-
Medtronic, Inc. (MDT) PT Raised to $100 at Stifel
-
Form 10-Q Medtronic plc For: Jan 26
-
Orchestra BioMed (OBIO) Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy f
-
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over
-
Form 4 Medtronic plc For: Feb 21 Filed by: Salmon Sean
-
Form 144 Medtronic plc Filed by: Salmon Sean
-
Medtronic, Inc. (MDT) PT Raised to $75 at UBS
-
Medtronic, Inc. (MDT) PT Raised to $92 at Oppenheimer
-
Medtronic, Inc. (MDT) PT Raised to $90 at Truist Securities
-
Medtronic, Inc. (MDT) PT Raised to $98 at Mizuho Securities
-
Medtronic, Inc. (MDT) PT Raised to $90 at Citi
-
Medtronic, Inc. (MDT) PT Lowered to $100 at Evercore ISI
-
Medtronic (MDT) gains after boosting full-year guidance
-
Medtronic (MDT) Tops Q3 EPS by 4c; raises FY24 Guidance
-
Medtronic lifts annual profit forecast, exits ventilator business
-
Medtronic (MDT) to Exit Ventilator Product Line, Reports Q3, Issues Guidance
-
Form 8-K Medtronic plc For: Feb 13
-
Medtronic reports third quarter fiscal 2024 financial results
-
Medtronic (MDT) call put ratio 4.2 calls to 1 put into quarter results
-
Medtronic (MDT) February weekly 85 straddle into quarter results
-
Form SC 13G/A Medtronic plc Filed by: VANGUARD GROUP INC
-
Form SC 13G/A Medtronic plc Filed by: BlackRock Inc.
Back to MDT Stock Lookup